M Emoto, T Anno, Y Sato, K Tanabe, S Okuya, … - Diabetes, 2001 - Am Diabetes Assoc Troglitazone is one of the thiazolidinediones, a new class of oral antidiabetic
compounds that are ligands of peroxisome proliferator–activated receptor-γ.
This study on vascular endothelial growth factor (VEGF), also known as ... Cited by 66 - Related articles - BL Direct - All 4 versions
- ►diabetesjournals.org [PDF] T Baba, K Shimada, S Neugebauer, D … - Diabetes care, 2001 - Am Diabetes Assoc In the Presidential Address in June of 1998 (1), I proudly announced that the
recently adopted Five Year Plan of the American Diabetes Association (ADA)
contained the goal of allocating one of ev- ery three dollars of total ... Cited by 34 - Related articles - BL Direct - All 4 versions
T Murata, Y Hata, T Ishibashi, S Kim, WA … - Archives of Ophthalmology, 2001 - archopht.ama-assn.org.p.angrylapdog.com Methods The ability of the TZDs troglitazone and rosiglitazone maleate (1-20
µmol/L) to inhibit retinal endothelial cell (REC) proliferation, migration,
tube formation, and signaling was determined in response to vascular ... Cited by 66 - Related articles - Cached - BL Direct - All 5 versions
K Yamakawa, M Hosoi, H Koyama, S Tanaka, S … - Biochemical and Biophysical Research …, 2000 - Elsevier Vascular endothelial growth factor (VEGF), expressed in a variety of mesenchymal
cells including vascular smooth muscle cells (VSMC), is a potent mitogen for
endothelial cells, and is used clinically applied for ischemic disease of ... Cited by 118 - Related articles - BL Direct - All 5 versions
[CITATION] Effects of treatment with rosiglitazone on myocardial blood flow in type 2 diabetes
J Kim, Y Oh, S Shinn - Experimental eye research, 2005 - Elsevier In the retinal microcirculation, there is a basal release of nitric oxide (NO)
which maintains the retinal blood flow. The proportions of endothelial cells and
pericytes in the retinal capillaries are almost equal, so pericytes appear ... Cited by 13 - Related articles - All 5 versions
CH Wang, RD Weisel, PP Liu, PWM Fedak, S … - Circulation, 2003 - Am Heart Assoc Mr S. is a 46-year-old East-Indian male with typical manifestations of the
cardiovascular dysmetabolic syndrome of insulin resistance (type II diabetes,
obesity, dyslipidemia, hypertension, and elevated levels of ... Cited by 89 - Related articles - BL Direct - All 6 versions
ST de Dios, KM Hannan, RJ Dilley, MA Hill, PJ … - Journal of Diabetes and its Complications, 2001 - Elsevier Diabetes is associated with a high level of mortality due to cardiovascular
disease resulting from accelerated coronary artery atherosclerosis. A current
focus for investigation of atherosclerotic mechanisms is the vascular ... Cited by 39 - Related articles - BL Direct - All 11 versions
M Holtkamp, R Zschenderlein, W Brück, J … - Acta neuropathologica, 2001 - Springer Abstract Although patient series of clinical, electrophys- iological, or
magnetic resonance imaging evidence for in- volvement of the central nervous
system in patients with chronic inflammatory demyelinating ... Cited by 5 - Related articles - BL Direct - All 4 versions
KC Silva, CC Pinto, SK Biswas, JB Lopes de … - Current Eye Research, 2007 - informahealthcare.com Inflammation is pivotal to the pathogenesis of diabetic retinopathy (DR).
Hypertension is the main secondary risk factor associated with DR. The
mechanisms by which hypertension increases the risk for DR are poorly ... Cited by 6 - Related articles - BL Direct - All 5 versions
